SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000; 31: 705711.
  • 2
    Victor MA, Arpi M, Bruun B, Jonsson V, Hansen MM. Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis. 1994; 26: 163170.
  • 3
    Krcmery V Jr., Pichna P, Oravcova E, et al. Stenotrophomonas maltophilia bactericidal in cancer patients: report on 31 cases. J Hosp Infect. 1996; 34: 7577.
  • 4
    Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine. 1990; 69: 296306.
  • 5
    Muder RR, Harris AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis. 1996; 22: 508512.
  • 6
    Jang TN, Wang FD, Wang LS, Liu CY, Liu IM. Xanthomonas maltophilia bacteremia: an analysis of 32 cases. J Formos Med Assoc. 1992; 91: 11701176.
  • 7
    Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW. Bacteremia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. Infection. 2002; 45: 4753.
  • 8
    Lai CH, Chi CY, Chen HP, et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004; 37: 350358.
  • 9
    Apisarnthanarak A, Mayfield JL, Garison T, et al. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol. 2003; 24: 269274.
  • 10
    Labarca JA, Leber AL, Kern VL, et al. Outbreak of Stenotrophomonas maltophilia bacteremia in allogeneic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis. 2000; 30: 195197.
  • 11
    Elting LS, Khardori N, Bodey GP, Fainstein V. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol. 1990; 11: 134138.
  • 12
    Schaumann R, Stein K, Eckhardt C, Ackermann G, Rodloff AC. Infections caused by Stenotrophomonas maltophilia—a prospective study. Infection. 2001; 29: 205208.
  • 13
    Hanes SD, Demirkan K, Tolley E, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis. 2002; 35: 228235.
  • 14
    Khardori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis. 1990; 12: 9971003.
  • 15
    Platsouka E, Routsi C, Chalkis A, Dimitriadou E, Paniara O, Roussos C. Stenotrophomonas maltophilia meningitis, bacteremia and respiratory infection. Scand J Infect Dis. 2002; 34: 391392.
  • 16
    Crum NF, Utz GC, Wallace MR. Stenotrophomonas maltophilia endocarditis. Scand J Infect Dis. 2002; 34: 925927.
  • 17
    Khan IA, Mehta NJ. Stenotrophomonas maltophilia endocarditis: a systematic review. Angiology. 2002; 53: 4955
  • 18
    Vartivarian SE, Papadakis KA, Anaissie EJ. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated. Arch Intern Med. 1996; 156: 433435.
  • 19
    Downhour NP, Petersen EA, Krueger TS, Tangella KV, Nix DE. Severe cellulitis/myositis caused by Stenotrophomonas maltophilia. Ann Pharmacother. 2002; 36: 6366.
  • 20
    Vartivarian SE, Papadakis KA, Palacios JA, Manning JT Jr., Anaissie EJ. Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum. Ann Intern Med. 1994; 121: 969973.
  • 21
    Doerr CA, Demmler GJ, Garcia-Prats JA, Brandt ML. Solitary pyogenic liver abscess in neonates: report of three cases and review of the literature. Pediatr Infect Dis J. 1994; 13: 6469.
  • 22
    Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002; 15; 34: 16531656.
  • 23
    Elvers KT, Leeming K, Lappin-Scott HM. Binary culture biofilm formation by Stenotrophomonas maltophilia and Fusarium oxysporum. J Ind Microbiol Biotechnol. 2001; 26: 178183.
  • 24
    Jucker BA, Harms H, Zehnder AJ. Adhesion of the positively charged bacterium Stenotrophomonas (Xanthomonas) maltophilia 70401 to glass and Teflon. J Bacteriol. 1996; 178: 54725479.
  • 25
    Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993; 168: 400407.
  • 26
    Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother. 1994; 38: 624627.
  • 27
    Morrison AJ Jr., Hoffmann KK, Wenzel RP. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol. 1986; 24: 5255.
  • 28
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13: 818829.
  • 29
    Mermel LA, Farr BM, Sherertz RJ, et al.; Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32: 12491272.
  • 30
    Young LS. Gram-negative bacillary colonization and bacteremia in the compromised host. Infection. 1982; 10: 319323.
  • 31
    Hanna H, Afif C, Alakech B, et al. Central venous catheter-related bacteremia due to Gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol. 2004; 25: 646649.